-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICENNA ANNOUNCES ORAL PRESENTATION OF TOPLINE DATA FROM THE PHASE 1/2 ABILITY-1 STUDY OF MDNA11 AT SITC 2026

Reuters·10/05/2026 13:00:04

Please log in to view news